As an associate in the Intellectual Property, Media, and Technology (IPMT) group, Nadia Aksentijevich enjoys a diverse practice of patent prosecution, IP litigation, and transactions. She leverages this wide range of knowledge, including her prior research experience at the National Institutes of Health, to understand and address each client's needs, whether she is negotiating a license deal or arguing for patent validity before the Patent Trademark Office.
Nadia focuses her litigation practice on the defense of trademarks and patents and has worked on teams representing major pharmaceutical and healthcare corporations. On the transactional side, Nadia has experience with both large-scale and start-up licensing deals in the bio-tech space and with research and development transactions more generally, including clinical trial agreements, master services agreements, and material transfer agreements.
She has experience prosecuting patent applications in the biological and chemical sciences and within a wide range of industries including network-based technologies. She counsels clients regarding patent issues, including non-infringement, invalidity, and patent prosecution strategies.
Nadia is also a contributor to IPMT's LimeGreen IP News, a blog that discusses key trends, developments, and events in intellectual property law.